Report Detail

Pharma & Healthcare Global Influenza Drugs and Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • RnM3373274
  • |
  • 02 May, 2019
  • |
  • Global
  • |
  • 122 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Scope of the Report:
The worldwide market for Influenza Drugs and Vaccines is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Influenza Drugs and Vaccines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
GlaxoSmithKline
Sanofi Pasteur, Inc.
CSL Limited
Astrazeneca
Protein Sciences Corporation
Serum Institute Of India Pvt. Ltd.
Emergent Biosolutions
Emergent Biosolutions
BioCryst Pharmaceuticals.Inc.
Alvogen
ABPI

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Zanamivir
Oseltamivir Phosphate
Peramivir
Trivalent
Quadrivalent

Market Segment by Applications, can be divided into
Hospitals
Research Laboratories
Pharmacies
Others

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Influenza Drugs and Vaccines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenza Drugs and Vaccines, with price, sales, revenue and global market share of Influenza Drugs and Vaccines in 2017 and 2018.
Chapter 3, the Influenza Drugs and Vaccines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenza Drugs and Vaccines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Influenza Drugs and Vaccines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Influenza Drugs and Vaccines sales channel, distributors, customers, research findings and conclusion, appendix and data source.


Table of Contents

    1 Market Overview

    • 1.1 Influenza Drugs and Vaccines Introduction
    • 1.2 Market Analysis by Type
      • 1.2.1 Zanamivir
      • 1.2.2 Oseltamivir Phosphate
      • 1.2.3 Peramivir
      • 1.2.4 Trivalent
      • 1.2.5 Quadrivalent
    • 1.3 Market Analysis by Applications
      • 1.3.1 Hospitals
      • 1.3.2 Research Laboratories
      • 1.3.3 Pharmacies
      • 1.3.4 Others
    • 1.4 Market Analysis by Regions
      • 1.4.1 North America (United States, Canada and Mexico)
        • 1.4.1.1 United States Market States and Outlook (2014-2024)
        • 1.4.1.2 Canada Market States and Outlook (2014-2024)
        • 1.4.1.3 Mexico Market States and Outlook (2014-2024)
      • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
        • 1.4.2.1 Germany Market States and Outlook (2014-2024)
        • 1.4.2.2 France Market States and Outlook (2014-2024)
        • 1.4.2.3 UK Market States and Outlook (2014-2024)
        • 1.4.2.4 Russia Market States and Outlook (2014-2024)
        • 1.4.2.5 Italy Market States and Outlook (2014-2024)
      • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
        • 1.4.3.1 China Market States and Outlook (2014-2024)
        • 1.4.3.2 Japan Market States and Outlook (2014-2024)
        • 1.4.3.3 Korea Market States and Outlook (2014-2024)
        • 1.4.3.4 India Market States and Outlook (2014-2024)
        • 1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
      • 1.4.4 South America, Middle East and Africa
        • 1.4.4.1 Brazil Market States and Outlook (2014-2024)
        • 1.4.4.2 Egypt Market States and Outlook (2014-2024)
        • 1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
        • 1.4.4.4 South Africa Market States and Outlook (2014-2024)
        • 1.4.4.5 Turkey Market States and Outlook (2014-2024)
    • 1.5 Market Dynamics
      • 1.5.1 Market Opportunities
      • 1.5.2 Market Risk
      • 1.5.3 Market Driving Force

    2 Manufacturers Profiles

    • 2.1 GlaxoSmithKline
      • 2.1.1 Business Overview
      • 2.1.2 Influenza Drugs and Vaccines Type and Applications
        • 2.1.2.1 Product A
        • 2.1.2.2 Product B
      • 2.1.3 GlaxoSmithKline Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.2 Sanofi Pasteur, Inc.
      • 2.2.1 Business Overview
      • 2.2.2 Influenza Drugs and Vaccines Type and Applications
        • 2.2.2.1 Product A
        • 2.2.2.2 Product B
      • 2.2.3 Sanofi Pasteur, Inc. Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.3 CSL Limited
      • 2.3.1 Business Overview
      • 2.3.2 Influenza Drugs and Vaccines Type and Applications
        • 2.3.2.1 Product A
        • 2.3.2.2 Product B
      • 2.3.3 CSL Limited Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.4 Astrazeneca
      • 2.4.1 Business Overview
      • 2.4.2 Influenza Drugs and Vaccines Type and Applications
        • 2.4.2.1 Product A
        • 2.4.2.2 Product B
      • 2.4.3 Astrazeneca Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.5 Protein Sciences Corporation
      • 2.5.1 Business Overview
      • 2.5.2 Influenza Drugs and Vaccines Type and Applications
        • 2.5.2.1 Product A
        • 2.5.2.2 Product B
      • 2.5.3 Protein Sciences Corporation Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.6 Serum Institute Of India Pvt. Ltd.
      • 2.6.1 Business Overview
      • 2.6.2 Influenza Drugs and Vaccines Type and Applications
        • 2.6.2.1 Product A
        • 2.6.2.2 Product B
      • 2.6.3 Serum Institute Of India Pvt. Ltd. Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.7 Emergent Biosolutions
      • 2.7.1 Business Overview
      • 2.7.2 Influenza Drugs and Vaccines Type and Applications
        • 2.7.2.1 Product A
        • 2.7.2.2 Product B
      • 2.7.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.8 Emergent Biosolutions
      • 2.8.1 Business Overview
      • 2.8.2 Influenza Drugs and Vaccines Type and Applications
        • 2.8.2.1 Product A
        • 2.8.2.2 Product B
      • 2.8.3 Emergent Biosolutions Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.9 BioCryst Pharmaceuticals.Inc.
      • 2.9.1 Business Overview
      • 2.9.2 Influenza Drugs and Vaccines Type and Applications
        • 2.9.2.1 Product A
        • 2.9.2.2 Product B
      • 2.9.3 BioCryst Pharmaceuticals.Inc. Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.10 Alvogen
      • 2.10.1 Business Overview
      • 2.10.2 Influenza Drugs and Vaccines Type and Applications
        • 2.10.2.1 Product A
        • 2.10.2.2 Product B
      • 2.10.3 Alvogen Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
    • 2.11 ABPI
      • 2.11.1 Business Overview
      • 2.11.2 Influenza Drugs and Vaccines Type and Applications
        • 2.11.2.1 Product A
        • 2.11.2.2 Product B
      • 2.11.3 ABPI Influenza Drugs and Vaccines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

    3 Global Influenza Drugs and Vaccines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

    • 3.1 Global Influenza Drugs and Vaccines Sales and Market Share by Manufacturer (2017-2018)
    • 3.2 Global Influenza Drugs and Vaccines Revenue and Market Share by Manufacturer (2017-2018)
    • 3.3 Market Concentration Rate
      • 3.3.1 Top 3 Influenza Drugs and Vaccines Manufacturer Market Share in 2018
      • 3.3.2 Top 6 Influenza Drugs and Vaccines Manufacturer Market Share in 2018
    • 3.4 Market Competition Trend

    4 Global Influenza Drugs and Vaccines Market Analysis by Regions

    • 4.1 Global Influenza Drugs and Vaccines Sales, Revenue and Market Share by Regions
      • 4.1.1 Global Influenza Drugs and Vaccines Sales and Market Share by Regions (2014-2019)
      • 4.1.2 Global Influenza Drugs and Vaccines Revenue and Market Share by Regions (2014-2019)
    • 4.2 North America Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 4.3 Europe Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 4.4 Asia-Pacific Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 4.5 South America Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 4.6 Middle East and Africa Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)

    5 North America Influenza Drugs and Vaccines by Country

    • 5.1 North America Influenza Drugs and Vaccines Sales, Revenue and Market Share by Country
      • 5.1.1 North America Influenza Drugs and Vaccines Sales and Market Share by Country (2014-2019)
      • 5.1.2 North America Influenza Drugs and Vaccines Revenue and Market Share by Country (2014-2019)
    • 5.2 United States Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 5.3 Canada Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 5.4 Mexico Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)

    6 Europe Influenza Drugs and Vaccines by Country

    • 6.1 Europe Influenza Drugs and Vaccines Sales, Revenue and Market Share by Country
      • 6.1.1 Europe Influenza Drugs and Vaccines Sales and Market Share by Country (2014-2019)
      • 6.1.2 Europe Influenza Drugs and Vaccines Revenue and Market Share by Country (2014-2019)
    • 6.2 Germany Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 6.3 UK Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 6.4 France Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 6.5 Russia Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 6.6 Italy Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)

    7 Asia-Pacific Influenza Drugs and Vaccines by Country

    • 7.1 Asia-Pacific Influenza Drugs and Vaccines Sales, Revenue and Market Share by Country
      • 7.1.1 Asia-Pacific Influenza Drugs and Vaccines Sales and Market Share by Country (2014-2019)
      • 7.1.2 Asia-Pacific Influenza Drugs and Vaccines Revenue and Market Share by Country (2014-2019)
    • 7.2 China Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 7.3 Japan Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 7.4 Korea Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 7.5 India Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 7.6 Southeast Asia Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)

    8 South America Influenza Drugs and Vaccines by Country

    • 8.1 South America Influenza Drugs and Vaccines Sales, Revenue and Market Share by Country
      • 8.1.1 South America Influenza Drugs and Vaccines Sales and Market Share by Country (2014-2019)
      • 8.1.2 South America Influenza Drugs and Vaccines Revenue and Market Share by Country (2014-2019)
    • 8.2 Brazil Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 8.3 Argentina Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 8.4 Colombia Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)

    9 Middle East and Africa Influenza Drugs and Vaccines by Countries

    • 9.1 Middle East and Africa Influenza Drugs and Vaccines Sales, Revenue and Market Share by Country
      • 9.1.1 Middle East and Africa Influenza Drugs and Vaccines Sales and Market Share by Country (2014-2019)
      • 9.1.2 Middle East and Africa Influenza Drugs and Vaccines Revenue and Market Share by Country (2014-2019)
    • 9.2 Saudi Arabia Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 9.3 Turkey Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 9.4 Egypt Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 9.5 Nigeria Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)
    • 9.6 South Africa Influenza Drugs and Vaccines Sales and Growth Rate (2014-2019)

    10 Global Influenza Drugs and Vaccines Market Segment by Type

    • 10.1 Global Influenza Drugs and Vaccines Sales, Revenue and Market Share by Type (2014-2019)
      • 10.1.1 Global Influenza Drugs and Vaccines Sales and Market Share by Type (2014-2019)
      • 10.1.2 Global Influenza Drugs and Vaccines Revenue and Market Share by Type (2014-2019)
    • 10.2 Zanamivir Sales Growth and Price
      • 10.2.1 Global Zanamivir Sales Growth (2014-2019)
      • 10.2.2 Global Zanamivir Price (2014-2019)
    • 10.3 Oseltamivir Phosphate Sales Growth and Price
      • 10.3.1 Global Oseltamivir Phosphate Sales Growth (2014-2019)
      • 10.3.2 Global Oseltamivir Phosphate Price (2014-2019)
    • 10.4 Peramivir Sales Growth and Price
      • 10.4.1 Global Peramivir Sales Growth (2014-2019)
      • 10.4.2 Global Peramivir Price (2014-2019)
    • 10.5 Trivalent Sales Growth and Price
      • 10.5.1 Global Trivalent Sales Growth (2014-2019)
      • 10.5.2 Global Trivalent Price (2014-2019)
    • 10.6 Quadrivalent Sales Growth and Price
      • 10.6.1 Global Quadrivalent Sales Growth (2014-2019)
      • 10.6.2 Global Quadrivalent Price (2014-2019)

    11 Global Influenza Drugs and Vaccines Market Segment by Application

    • 11.1 Global Influenza Drugs and Vaccines Sales Market Share by Application (2014-2019)
    • 11.2 Hospitals Sales Growth (2014-2019)
    • 11.3 Research Laboratories Sales Growth (2014-2019)
    • 11.4 Pharmacies Sales Growth (2014-2019)
    • 11.5 Others Sales Growth (2014-2019)

    12 Influenza Drugs and Vaccines Market Forecast (2019-2024)

    • 12.1 Global Influenza Drugs and Vaccines Sales, Revenue and Growth Rate (2019-2024)
    • 12.2 Influenza Drugs and Vaccines Market Forecast by Regions (2019-2024)
      • 12.2.1 North America Influenza Drugs and Vaccines Market Forecast (2019-2024)
      • 12.2.2 Europe Influenza Drugs and Vaccines Market Forecast (2019-2024)
      • 12.2.3 Asia-Pacific Influenza Drugs and Vaccines Market Forecast (2019-2024)
      • 12.2.4 South America Influenza Drugs and Vaccines Market Forecast (2019-2024)
      • 12.2.5 Middle East and Africa Influenza Drugs and Vaccines Market Forecast (2019-2024)
    • 12.3 Influenza Drugs and Vaccines Market Forecast by Type (2019-2024)
      • 12.3.1 Global Influenza Drugs and Vaccines Sales Forecast by Type (2019-2024)
      • 12.3.2 Global Influenza Drugs and Vaccines Market Share Forecast by Type (2019-2024)
    • 12.4 Influenza Drugs and Vaccines Market Forecast by Application (2019-2024)
      • 12.4.1 Global Influenza Drugs and Vaccines Sales Forecast by Application (2019-2024)
      • 12.4.2 Global Influenza Drugs and Vaccines Market Share Forecast by Application (2019-2024)

    13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
      • 13.1.1 Direct Marketing
      • 13.1.2 Indirect Marketing
      • 13.1.3 Marketing Channel Future Trend
    • 13.2 Distributors, Traders and Dealers

    14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Summary:
      Get latest Market Research Reports on Influenza Drugs and Vaccines . Industry analysis & Market Report on Influenza Drugs and Vaccines is a syndicated market report, published as Global Influenza Drugs and Vaccines Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024. It is complete Research Study and Industry Analysis of Influenza Drugs and Vaccines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,780.52
      4,170.78
      5,561.04
      3,257.28
      4,885.92
      6,514.56
      547,682.40
      821,523.60
      1,095,364.80
      290,545.20
      435,817.80
      581,090.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report